What does COVID-19 have to do with the brain?
COVID-19 syndrome includes neurological symptoms in over 30% of patients. This webinar will address molecular approaches from both cellular and organismal viewpoints. How SARS-COV-2 affects the human brain is an important approach to developing diagnostics, and then therapeutic agents, to help patients.
WELCOME ADDRESS
Luiz Eugênio Mello
Scientific Director, FAPESP
MODERATOR:
Daniel Martins-de-Souza
University of Campinas (UNICAMP) and FAPESP
SPEAKERS:
Helena Radbruch
Charité Universitaetsmedizin Berlin
Marcelo Mori
University of Campinas (UNICAMP)
Jean Pierre Peron
Institute of Biomedical Sciences, University of São Paulo (ICB/USP)
Marília Zaluar Guimarães
D’Or Institute for Research and Education (IDOR)
and Federal University of Rio de Janeiro (UFRJ)
There will be no certificate/declaration of presence
for events broadcast on YouTube.
You can participate in a Q & A panel. Please, send your comments
and questions (in English or Portuguese) to live@fapesp.br.
Supported by: